BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20691690)

  • 21. Regulation of human aromatase cytochrome P450 gene expression.
    Simpson ER; Kilgore MW; Mahendroo MS; Means GD; Corbin CJ; Mendelson CR
    J Steroid Biochem Mol Biol; 1992 Dec; 43(8):923-30. PubMed ID: 22217837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the bovine aromatase cytochrome P450 gene (Cyp19) is primarily regulated by promoter 2 in bovine follicles and by promoter 1.1 in corpora lutea.
    Lenz S; Pöhland R; Becker F; Vanselow J
    Mol Reprod Dev; 2004 Apr; 67(4):406-13. PubMed ID: 14991731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphenol A downregulates CYP19 transcription in JEG-3 cells.
    Huang H; Leung LK
    Toxicol Lett; 2009 Sep; 189(3):248-52. PubMed ID: 19539015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.
    Demura M; Martin RM; Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Mendonca BB; Hanaki K; Kanzaki S; Rhoads DB; Misra M; Bulun SE
    Hum Mol Genet; 2007 Nov; 16(21):2529-41. PubMed ID: 17584767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative detection of alternatively spliced transcripts of the aromatase cytochrome P450 (CYP19) gene in aromatase-expressing human cells by competitive RT-PCR.
    Agarwal VR; Bulun SE; Simpson ER
    Mol Cell Probes; 1995 Dec; 9(6):453-64. PubMed ID: 8808317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of endocrine-related gene expression in placental choriocarcinoma cell lines following DNA methylation knock-down.
    Hogg K; Robinson WP; Beristain AG
    Mol Hum Reprod; 2014 Jul; 20(7):677-89. PubMed ID: 24623739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bovine large luteal cells show increasing de novo DNA methylation of the main ovarian CYP19A1 promoter P2.
    Spitschak M; Vanselow J
    Gen Comp Endocrinol; 2012 Aug; 178(1):37-45. PubMed ID: 22531467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic regulation of maspin expression in the human placenta.
    Dokras A; Coffin J; Field L; Frakes A; Lee H; Madan A; Nelson T; Ryu GY; Yoon JG; Madan A
    Mol Hum Reprod; 2006 Oct; 12(10):611-7. PubMed ID: 16936308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organization of the human aromatase p450 (CYP19) gene.
    Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
    Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating DNA methylation and gene expression variability in the human term placenta.
    Avila L; Yuen RK; Diego-Alvarez D; Peñaherrera MS; Jiang R; Robinson WP
    Placenta; 2010 Dec; 31(12):1070-7. PubMed ID: 20947161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
    Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of aromatase gene expression in purified germ cells of adult male rats: effects of transforming growth factor beta, tumor necrosis factor alpha, and cyclic adenosine 3',5'-monosphosphate.
    Bourguiba S; Chater S; Delalande C; Benahmed M; Carreau S
    Biol Reprod; 2003 Aug; 69(2):592-601. PubMed ID: 12700195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressional and epigenetic alterations of placental matrix metalloproteinase 9 in preeclampsia.
    Wang Z; Lu S; Liu C; Zhao B; Pei K; Tian L; Ma X
    Gynecol Endocrinol; 2010 Feb; 26(2):96-102. PubMed ID: 19724956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase expression in the human temporal cortex.
    Yague JG; Muñoz A; de Monasterio-Schrader P; Defelipe J; Garcia-Segura LM; Azcoitia I
    Neuroscience; 2006; 138(2):389-401. PubMed ID: 16426763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological concentration of resveratrol suppresses aromatase in JEG-3 cells.
    Wang Y; Leung LK
    Toxicol Lett; 2007 Sep; 173(3):175-80. PubMed ID: 17766065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DNA methylation profile in human placental tissues].
    Tolmacheva EN; Kashevarova AA; Skriabin NA; Lebedev IN
    Mol Biol (Mosk); 2011; 45(3):538-45. PubMed ID: 21790017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation status of human chorionic gonadotropin beta subunit promoter and TFAP2A expression as factors regulating CGB gene expression in placenta.
    Głodek A; Kubiczak MJ; Walkowiak GP; Nowak-Markwitz E; Jankowska A
    Fertil Steril; 2014 Oct; 102(4):1175-1182.e8. PubMed ID: 25063728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of the placental epigenetic signature of the maspin gene in maternal plasma.
    Chim SS; Tong YK; Chiu RW; Lau TK; Leung TN; Chan LY; Oudejans CB; Ding C; Lo YM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14753-8. PubMed ID: 16203989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.